The
COVID-19 pandemic exerts
inflammation-related parasympathetic complications and post-
infection manifestations with major inter-individual variability. To seek the corresponding transcriptomic origins for the impact of
COVID-19 infection and its aftermath consequences, we sought the relevance of long and short non-coding RNAs (ncRNAs) for susceptibility to
COVID-19 infection. We selected
inflammation-prone men and women of diverse ages among the cohort of Genome Tissue expression (GTEx) by mining
RNA-seq datasets from their lung, and blood tissues, followed by quantitative qRT-PCR, bioinformatics-based network analyses and thorough statistics compared to brain cell culture and
infection tests with
COVID-19 and H1N1 viruses. In lung tissues from 57
inflammation-prone, but not other GTEx donors, we discovered sharp declines of the lung pathology-associated ncRNA DANCR and the nuclear paraspeckles forming neuroprotective ncRNA NEAT1. Accompanying increases in the
acetylcholine-regulating transcripts capable of controlling
inflammation co-appeared in SARS-CoV-2 infected but not H1N1
influenza infected lung cells. The lung cells-characteristic DANCR and NEAT1 association with
inflammation-controlling transcripts could not be observed in blood cells, weakened with age and presented sex-dependent links in GTEx lung
RNA-seq dataset. Supporting active involvement in the inflammatory risks accompanying
COVID-19, DANCR's decline associated with decrease of the COVID-19-related cellular transcript ACE2 and with sex-related increases in coding transcripts potentiating
acetylcholine signaling. Furthermore,
transcription factors (TFs) in lung, brain and cultured infected cells created networks with the candidate transcripts, indicating tissue-specific expression patterns. Supporting links of post-
infection inflammatory and cognitive damages with
cholinergic mal-functioning, man and woman-originated cultured cholinergic neurons presented differentiation-related increases of DANCR and NEAT1 targeting
microRNAs. Briefly, changes in ncRNAs and TFs from
inflammation-prone human lung tissues, SARS-CoV-2-infected lung cells and man and woman-derived differentiated cholinergic neurons reflected the inflammatory pathobiology related to
COVID-19. By shifting ncRNA differences into comparative diagnostic and therapeutic profiles, our
RNA-sequencing based Resource can identify ncRNA regulating candidates for
COVID-19 and its associated immediate and predicted long-term
inflammation and neurological complications, and sex-related
therapeutics thereof. Our findings encourage diagnostics of involved tissue, and further investigation of NEAT1-inducing
statins and
anti-cholinergic medications in the
COVID-19 context.